Assessment of a Mobile App by Adolescents and Young Adults With Cystic Fibrosis.  I. Rudolf, K. Pieper, H. Nolte, S. Junge, C. Dopfer, A. Sauer-Heilborn, F. C. Ringshausen, B. Tümmler, U. von Jan, U.-V. Albrecht, J. Fuge, G. Hansen, A.-M. Dittrich. JMIR Mhealth Uhealth. 2019. 7(11):e12442. IF: 4.3

IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease. M. Hagner, M. Albrecht, M.Guerra, P.Braubach, O. Halle, Z. Zhou-Suckow, S. Butz, D. Jonigk, G.Hansen, C. Schultz, A.-M. Dittrich, M. A Mall.  Eur Respir J2020. 

Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS): A Randomized, Double-Blind, Controlled Study. M. Stahl, M. O. Wielpütz, I. Ricklefs, C. Dopfer, S. Barth, A. Schlegtendal, S. Y Graeber, O. Sommerburg, G. Diekmann, J. Hüsing, C. Koerner-Rettberg, L. Nährlich, A.-M. Dittrich, M. V. Kopp, M. A Mall.  Am J Respir Crit Care Med. 2018.199(10):1238. IF: 17.4

Superior suppressive capacity of skin Tregs compared to lung Tregs in a model of epicutaneous priming.  S. Mahapatra, M. Albrecht, A. M. Baru, T. Sparwasser, C. Herrick, A.-M. Dittrich. J Invest Dermatol. 2015.135(10):2418-26. IF: 7.1

T(H)17 cells mediate pulmonary collateral priming. M. Albrecht, H.-C. Chen, P. Preston-Hurlburt, P. Ranney, H.-G. Hoymann, J. Maxeiner, V. Staudt, C. Taube, H. K. Bottomly, A.-M. Dittrich.  J Allergy Clin Immunol. 2011. 128:168-177. IF: 10.2

ICOS is an inducible T-cell costimulator structurally and functionally related to CD28. A. Hutloff, A.-M. Dittrich, K. C. Beier, B. Eljaschewitsch, R. Kraft, I. Anagnostopoulos, R. A. Kroczek. Nature 1999.397:263-266. IF: 42.7

Weitere Publikationen